Overexpression of epithelial growth factor receptor (EGFR) predicts better response to neo-adjuvant chemotherapy in patients with triple-negative breast cancer

Table 2 Correlations between Triple Negative Status and Pathological Factors

Factors	TNBC	Non-TNBC	P^*
	No. of Patients	No. of Patients
Histology
Ductal	38	144	0.534
Nonductal	2	14
Prechemotherapy T stage
T1	0	10	0.218
T2- T4	40	148
Prechemotherapy N stage
N0	14	46	0.469
N1- N3	26	112
Histological grade
I - II	18	78	0.622
III	22	80
EGFR
Positive	10	28	0.296
Negative	30	130
Pathologic Response
pCR	10	14	0.012
RD	30	144

ISSN: 1479-5876